In that study, ATR, ATM, and DNA-PKcs inhibitors were tested for potential enhancement effects, with the endpoints being clonogenic survival and 3D spheroid growth rate, in HPV-positive and HPV-negative HNSCC cells exposed to photon or proton radiation. This evidence concerns the gene ATR and head and neck squamous cell carcinoma.